Compare Eli Lilly And Co (LLY) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Open Text Corporation — how do they compare? Eli Lilly And Co trades at $1,177.75 (market cap $1.04T), while Open Text Corporation trades at $23.7 (market cap $5.61B). The key difference: Eli Lilly And Co is far larger — about 185.4× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.82%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Open Text Corporation for 23 Days on average.
| LLY | OTEX | |
|---|---|---|
Market Cap | $1.04T | $5.61B |
Volume | 3,064,878 | 1,197,475 |
Sector | Health | Technology |
52-Week High | $1.28K | $39.69 |
52-Week Low | $799.57 | $20.01 |
Typical Hold Time | 93 Days | 23 Days |
Enterprise Value | $1.09T | $10.63B |
Dividend Yield | 0.59% | 4.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,179.27, down 0.79% on the day, with a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 expectation. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing its market leadership.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include competitive pressures in the obesity drug market and execution challenges in scaling production. With a consensus price target of $1,350, representing ~14% upside, the stock offers growth potential but requires monitoring of pipeline progress and market dynamics.
OpenText (OTEX) trades at $23.695, up 2.4% today, with a bearish technical signal despite recent earnings beats. The stock is valued at a P/E of 9.01 and P/S of 1.1, below sector averages, while showing strong profitability with a net margin of 12.26%. Recent news highlights a $1 billion senior secured notes offering and a partnership with Cohere to advance AI capabilities, indicating strategic debt management and growth initiatives.
The outlook is mixed: valuation discounts and cloud growth present opportunities, but high debt and bearish technicals pose risks. Analysts are cautiously optimistic with a $28.30 price target, though execution on AI integration and debt reduction will be critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
